NOTA.F
Novartis AG
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
130.00
▼ 5.00 (3.70%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
130.00
Prev close
135.00
Day high
130.00
Day low
130.00
Volume
80
Market cap
$247.09B
P/E (TTM)
22.93
52W range
101.50 – 145.00
Day trading desk
Gap from prior close
-3.70%
Prior close 135.00
VWAP
130.00
0.00% from price
Relative volume
2.96×
Unusually busy
Session range
—
130.00 – 130.00
Position in range
—
—
ATR (14D)
1.86
1.43% of price
Prior day high
135.00
PDH
Prior day low
135.00
PDL
Bid / ask spread
—
Quote not published
Session volume
80
Avg 27
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.78%
+2.1%
1M
-0.76%
-4.5%
3M
+1.56%
-1.5%
6M
-6.47%
-17.5%
YTD
+11.11%
-1.2%
1Y
+21.50%
+1.5%
3Y
+45.83%
-28.3%
5Y
+88.70%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NOTA.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
228.09K
Total on file
Fundamentals
Market cap$247.09B
Enterprise value$288.89B
Revenue (TTM)$56.69B
Gross profit$42.51B
EBITDA$23.10B
Net income$12.76B
EPS (TTM)$5.67
Free cash flow$11.90B
Total cash$7.62B
Total debt$49.01B
Book value / share$18.89
Shares outstanding1.90B
Float1.86B
Short % of float—
Dividend yield3.19%
Beta (5Y)0.49
Valuation & profitability ratios
Trailing P/E22.93
Forward P/E19.26
PEG ratio3.47
Price / sales—
Price / book6.88
EV / revenue5.10
EV / EBITDA12.51
Gross margin74.98%
Operating margin34.62%
Profit margin22.50%
Return on equity30.35%
Return on assets10.25%
Debt / equity116.85
Current ratio0.86
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $56.67B | $51.72B | $46.66B | $43.46B | +9.6% |
| Operating revenue | $54.53B | $50.32B | $45.44B | $42.21B | +8.4% |
| Cost of revenue | $13.70B | $12.83B | $12.47B | $11.58B | +6.8% |
| Gross profit | $42.98B | $38.90B | $34.19B | $31.88B | +10.5% |
| Research & development | $11.20B | $10.02B | $11.37B | $9.17B | +11.8% |
| Selling, general & admin | $13.25B | $12.57B | $12.52B | $12.19B | +5.4% |
| Total operating expense | $25.33B | $24.35B | $24.42B | $23.93B | +4.0% |
| Operating income | $17.64B | $14.54B | $9.77B | $7.95B | +21.3% |
| Net interest income | -$980.00M | -$686.00M | -$419.00M | -$574.00M | -42.9% |
| Pre-tax income | $16.35B | $13.64B | $9.12B | $7.18B | +19.9% |
| Tax provision | $2.38B | $1.70B | $551.00M | $1.13B | +40.2% |
| Net income | $13.98B | $11.94B | $14.85B | $6.96B | +17.1% |
| Net income to common | $13.98B | $11.94B | $14.85B | $6.96B | +17.1% |
| Basic EPS | 7.21 | 5.92 | 7.15 | 3.19 | +21.8% |
| Diluted EPS | 7.15 | 5.87 | 7.10 | 3.17 | +21.8% |
| EBIT | $17.50B | $14.65B | $9.98B | $7.98B | +19.5% |
| EBITDA | $22.82B | $20.71B | $18.25B | $14.68B | +10.2% |
| Basic shares | 1.94B | 2.02B | 2.08B | 2.18B | -3.9% |
| Diluted shares | 1.96B | 2.04B | 2.09B | 2.20B | -3.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.44B | $11.46B | $13.39B | $7.52B | — | -0.2% |
| Cash & short-term investments | $11.53B | $13.35B | $13.96B | $18.61B | — | -13.6% |
| Accounts receivable | $8.94B | $7.42B | $7.11B | $8.07B | — | +20.4% |
| Inventory | $6.27B | $5.72B | $5.91B | $7.17B | — | +9.5% |
| Total current assets | $30.46B | $29.70B | $30.48B | $36.91B | — | +2.5% |
| Property, plant & equipment | $12.35B | $10.87B | $10.92B | $12.20B | — | +13.6% |
| Goodwill & intangibles | $54.98B | $51.67B | $50.22B | $60.95B | — | +6.4% |
| Total assets | $110.95B | $102.25B | $99.94B | $117.45B | — | +8.5% |
| Total current liabilities | $27.28B | $28.69B | $26.39B | $28.66B | — | -4.9% |
| Current debt | $5.52B | $8.09B | $6.08B | $5.88B | — | -31.7% |
| Long-term debt | $27.93B | $21.37B | $18.44B | $20.24B | — | +30.7% |
| Total debt | $35.38B | $31.26B | $26.35B | $27.91B | — | +13.2% |
| Total liabilities | $64.40B | $58.12B | $53.20B | $58.03B | — | +10.8% |
| Retained earnings | — | $46.56B | $49.65B | $63.54B | $70.99B | — |
| Shareholder equity | $46.13B | $44.05B | $46.67B | $59.34B | — | +4.7% |
| Working capital | $3.18B | $1.01B | $4.09B | $8.25B | — | +214.4% |
| Net tangible assets | -$8.85B | -$7.63B | -$3.55B | -$1.60B | — | -16.0% |
| Shares issued | 2.11B | 2.19B | 2.28B | 2.40B | — | -3.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $13.97B | $11.94B | $8.57B | $6.05B | +17.0% |
| Depreciation & amortisation | $5.33B | $6.07B | $8.28B | $6.71B | -12.3% |
| Stock-based compensation | $1.10B | $1.04B | $865.00M | $791.00M | +5.0% |
| Change in working capital | -$1.58B | -$706.00M | -$369.00M | -$796.00M | -123.4% |
| Operating cash flow | $19.14B | $17.62B | $14.46B | $14.24B | +8.7% |
| Capital expenditure | -$3.90B | -$3.81B | -$2.75B | -$2.24B | -2.3% |
| Investing cash flow | -$4.88B | -$7.51B | $5.60B | $1.47B | +35.1% |
| Share buybacks | -$9.21B | -$8.33B | -$8.72B | -$10.65B | -10.6% |
| Dividends paid | -$7.82B | -$7.62B | -$7.25B | -$7.51B | -2.5% |
| Financing cash flow | -$14.87B | -$11.74B | -$14.28B | -$20.56B | -26.6% |
| Free cash flow | $15.24B | $13.80B | $11.71B | $12.00B | +10.4% |
| End cash position | $11.44B | $11.46B | $13.39B | $7.52B | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $14.95B | $13.52B | $13.86B | $14.36B | $14.84B | — | +10.6% |
| Operating revenue | $14.41B | $13.11B | $13.34B | $13.91B | $14.05B | — | +9.9% |
| Cost of revenue | $3.71B | $3.46B | $3.61B | $3.54B | $3.32B | — | +7.3% |
| Gross profit | $11.24B | $10.06B | $10.25B | $10.82B | $11.51B | — | +11.7% |
| Research & development | $2.85B | $2.74B | $3.16B | $2.94B | $2.73B | — | +3.9% |
| Selling, general & admin | $3.24B | $3.14B | $3.44B | $3.31B | $3.44B | — | +3.2% |
| Total operating expense | $6.49B | $5.83B | $6.63B | $6.32B | $6.65B | — | +11.3% |
| Operating income | $4.75B | $4.24B | $3.62B | $4.50B | $4.86B | — | +12.2% |
| Net interest income | -$479.00M | -$393.00M | -$96.00M | -$301.00M | -$330.00M | — | -21.9% |
| Pre-tax income | $4.27B | $3.84B | $3.22B | $4.20B | $4.53B | — | +11.2% |
| Tax provision | $1.01B | $683.00M | $814.00M | $266.00M | $507.00M | — | +48.2% |
| Net income | $3.26B | $3.16B | $2.41B | $3.93B | $4.04B | — | +3.4% |
| Net income to common | $3.26B | $3.16B | $2.41B | $3.93B | $4.04B | — | +3.4% |
| Basic EPS | 1.71 | 1.65 | 1.26 | — | 2.07 | 1.83 | +3.6% |
| Diluted EPS | 1.71 | 1.65 | 1.25 | — | 2.06 | 1.82 | +3.6% |
| EBIT | $4.73B | $4.18B | $3.52B | $4.48B | $4.82B | — | +13.1% |
| EBITDA | $6.13B | $5.41B | $5.07B | $5.84B | $6.08B | — | +13.3% |
| Basic shares | 1.91B | 1.91B | 1.91B | — | 1.95B | 1.97B | -0.2% |
| Diluted shares | 1.91B | 1.92B | 1.93B | — | 1.96B | 1.98B | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.62B | $6.88B | $11.44B | $9.56B | $6.66B | — | +10.7% |
| Cash & short-term investments | $7.69B | $6.98B | $11.53B | $9.75B | $7.00B | — | +10.2% |
| Accounts receivable | $9.64B | $9.39B | $8.94B | $8.84B | $9.06B | — | +2.7% |
| Inventory | $6.22B | $6.29B | $6.27B | $6.42B | $6.31B | — | -1.0% |
| Total current assets | $27.35B | $26.61B | $30.46B | $28.20B | $25.94B | — | +2.8% |
| Property, plant & equipment | $12.27B | $12.24B | $12.35B | $11.99B | $11.83B | — | +0.2% |
| Goodwill & intangibles | $68.84B | $67.03B | $54.98B | $54.59B | $54.79B | — | +2.7% |
| Total assets | $122.03B | $118.53B | $110.95B | $107.29B | $104.39B | — | +3.0% |
| Total current liabilities | $31.75B | $31.37B | $27.28B | $32.00B | $31.71B | — | +1.2% |
| Current debt | $9.59B | $7.62B | $5.52B | $7.52B | $8.31B | — | +25.9% |
| Long-term debt | $37.49B | $37.45B | $27.93B | $22.60B | $22.47B | — | +0.1% |
| Total debt | $49.01B | $47.00B | $35.38B | $32.02B | $32.64B | — | +4.3% |
| Total liabilities | $80.09B | $79.61B | $64.40B | $62.54B | $62.34B | — | +0.6% |
| Retained earnings | $39.65B | $37.25B | — | $43.51B | $41.53B | $39.84B | +6.4% |
| Shareholder equity | $41.54B | $38.51B | $46.13B | $44.33B | $41.98B | — | +7.9% |
| Working capital | -$4.40B | -$4.77B | $3.18B | -$3.80B | -$5.78B | — | +7.8% |
| Net tangible assets | -$27.30B | -$28.52B | -$8.85B | -$10.26B | -$12.81B | — | +4.3% |
| Shares issued | 1.90B | 2.03B | 2.11B | 1.92B | 2.07B | — | -6.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $3.26B | $3.16B | $2.40B | $3.93B | $4.02B | — | +3.2% |
| Depreciation & amortisation | $1.40B | $1.23B | $1.55B | $1.36B | $1.26B | — | +14.0% |
| Stock-based compensation | $267.00M | $303.00M | $299.00M | $268.00M | $267.00M | — | -11.9% |
| Change in working capital | $232.00M | -$787.00M | -$1.59B | $1.34B | $442.00M | — | +129.5% |
| Operating cash flow | $5.88B | $3.68B | $2.26B | $6.57B | $6.66B | — | +60.0% |
| Capital expenditure | -$758.00M | -$807.00M | -$1.02B | -$831.00M | -$558.00M | — | +6.1% |
| Investing cash flow | -$3.10B | -$11.74B | -$2.10B | -$860.00M | -$2.24B | — | +73.5% |
| Share buybacks | -$1.20B | -$1.88B | -$1.48B | -$2.30B | -$2.71B | — | +36.1% |
| Dividends paid | -$2.87B | -$6.20B | $0 | — | -$2.48B | -$5.33B | +53.7% |
| Financing cash flow | -$2.02B | $3.58B | $1.68B | -$2.79B | -$5.21B | — | -156.4% |
| Free cash flow | $5.12B | $2.87B | $1.25B | $5.74B | $6.11B | — | +78.6% |
| End cash position | $7.62B | $6.88B | $11.44B | $9.56B | $6.66B | — | +10.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $14.65B | +2.0% |
| Next quarter | — | — | $14.89B | +7.4% |
| Current year | — | — | $57.65B | +1.7% |
| Next year | — | — | $61.31B | +6.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.01%
Held by institutions7.27%
Institutions holding1.81K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
131.30
-0.99% from price
SMA 20
133.00
-2.26% from price
SMA 50
132.82
-2.12% from price
SMA 100
129.40
+0.47% from price
SMA 200
126.10
+3.09% from price
EMA 12
131.58
-1.20% from price
EMA 26
132.17
-1.64% from price
EMA 50
131.80
-1.36% from price
RSI (14)
45.9
Neutral
MACD (12,26,9)
-0.59
Hist -0.19
ATR (14)
1.86
1.43% of price
Realised vol 30D
29.2%
Annualised
Bollinger upper
139.10
20, 2σ
Bollinger lower
126.90
20, 2σ
50 / 200 cross
Golden
132.82 vs 126.10
Trend bias
Above 200
+3.09%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.32
Less volatile than market
Correlation to SPY
-0.12
Largely independent
Realised vol 30D
29.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-17.9%
Peak to trough
Max drawdown 5Y
-17.9%
Peak to trough
ATR 14
1.86
1.43% of price
Beta (reported)
0.49
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 26, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jan 6, 26 | Barclays | UPGRADE | Underweight | Equal-Weight |
| Dec 8, 25 | JP Morgan | UPGRADE | Neutral | Overweight |
| Sep 12, 25 | Goldman Sachs | DOWNGRADE | Neutral | Sell |
| Feb 13, 25 | UBS | DOWNGRADE | Buy | Neutral |
| Nov 19, 24 | Erste Group | DOWNGRADE | Buy | Hold |
| Oct 30, 24 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Sep 11, 24 | B of A Securities | DOWNGRADE | Buy | Neutral |
| Sep 5, 24 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Sep 3, 24 | Jefferies | DOWNGRADE | Buy | Hold |
| Jul 2, 24 | Jefferies | MAINTAINED | Buy | Buy |
| Apr 24, 24 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
Dividends & splits
Forward rate$4.15 / yr
Forward yield3.19%
5-year avg yield3.52%
Payout ratio71.60%
Ex-dividend dateMar 11, 2026
Next pay date—
Last split—
Split date—
Headlines
Raphinha, Lopez hit braces as Barcelona trounce Elche
AFP · 12m ago
Amorim starts Serie A life with Milan win, Juve edge Frosinone
AFP · 16m ago
Lawsuit filed in Napali coast ‘doors-off’ helicopter tour crash
The Honolulu Star-Advertiser · 16m ago
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Motley Fool · 17m ago
Liquor industry struggles grow with another Chapter 7 filing
TheStreet · 19m ago
Media Advisory: Housing Announcement in Toronto
CNW Group · 22m ago
Dow Jones Futures Due With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 28m ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Motley Fool · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.